BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gromada J, Høy M, Buschard K, Salehi A, Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol. 2001;535:519-532. [PMID: 11533141 DOI: 10.1111/j.1469-7793.2001.00519.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gyulkhandanyan AV, Lu H, Lee SC, Bhattacharjee A, Wijesekara N, Fox JE, MacDonald PE, Chimienti F, Dai FF, Wheeler MB. Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem 2008;283:10184-97. [PMID: 18250168 DOI: 10.1074/jbc.M707005200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
2 Galsgaard KD, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Glucagon Receptor Signaling and Lipid Metabolism. Front Physiol 2019;10:413. [PMID: 31068828 DOI: 10.3389/fphys.2019.00413] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
3 Nagy G, Reim K, Matti U, Brose N, Binz T, Rettig J, Neher E, Sørensen JB. Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25. Neuron 2004;41:417-29. [PMID: 14766180 DOI: 10.1016/s0896-6273(04)00038-8] [Cited by in Crossref: 139] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
4 Quoix N, Cheng-Xue R, Mattart L, Zeinoun Z, Guiot Y, Beauvois MC, Henquin JC, Gilon P. Glucose and pharmacological modulators of ATP-sensitive K+ channels control [Ca2+]c by different mechanisms in isolated mouse alpha-cells. Diabetes 2009;58:412-21. [PMID: 19008345 DOI: 10.2337/db07-1298] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
5 Müller TD, Finan B, Clemmensen C, DiMarchi RD, Tschöp MH. The New Biology and Pharmacology of Glucagon. Physiol Rev 2017;97:721-66. [PMID: 28275047 DOI: 10.1152/physrev.00025.2016] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 30.3] [Reference Citation Analysis]
6 Braun M. The somatostatin receptor in human pancreatic β-cells. Vitam Horm 2014;95:165-93. [PMID: 24559918 DOI: 10.1016/B978-0-12-800174-5.00007-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
7 Yosten GLC. Alpha cell dysfunction in type 1 diabetes. Peptides 2018;100:54-60. [PMID: 29412832 DOI: 10.1016/j.peptides.2017.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
8 Santos-Silva JC, Ribeiro RA, Vettorazzi JF, Irles E, Rickli S, Borck PC, Porciuncula PM, Quesada I, Nadal A, Boschero AC, Carneiro EM. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice. Amino Acids 2015;47:1533-48. [PMID: 25940922 DOI: 10.1007/s00726-015-1988-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
9 Gylfe E. Glucose control of glucagon secretion-'There's a brand-new gimmick every year'. Ups J Med Sci 2016;121:120-32. [PMID: 27044660 DOI: 10.3109/03009734.2016.1154905] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
10 Gao R, Yang T, Zhang Q. δ-Cells: The Neighborhood Watch in the Islet Community. Biology (Basel) 2021;10:74. [PMID: 33494193 DOI: 10.3390/biology10020074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Leiss V, Friebe A, Welling A, Hofmann F, Lukowski R. Cyclic GMP kinase I modulates glucagon release from pancreatic α-cells. Diabetes 2011;60:148-56. [PMID: 20978093 DOI: 10.2337/db10-0595] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
12 Pereverzev A, Salehi A, Mikhna M, Renström E, Hescheler J, Weiergräber M, Smyth N, Schneider T. The ablation of the Cav2.3/E-type voltage-gated Ca2+ channel causes a mild phenotype despite an altered glucose induced glucagon response in isolated islets of Langerhans. European Journal of Pharmacology 2005;511:65-72. [DOI: 10.1016/j.ejphar.2005.01.044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
13 Eiden LE. Signaling During Exocytosis. Handbook of Cell Signaling. Elsevier; 2003. pp. 375-92. [DOI: 10.1016/b978-012124546-7/50689-6] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
14 Schwetz TA, Ustione A, Piston DW. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms. Am J Physiol Endocrinol Metab 2013;304:E211-21. [PMID: 23211512 DOI: 10.1152/ajpendo.00374.2012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
15 Braun M, Wendt A, Buschard K, Salehi A, Sewing S, Gromada J, Rorsman P. GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin. J Physiol 2004;559:397-409. [PMID: 15235087 DOI: 10.1113/jphysiol.2004.066563] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
16 Vierra NC, Dickerson MT, Jordan KL, Dadi PK, Katdare KA, Altman MK, Milian SC, Jacobson DA. TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 2018;9:84-97. [PMID: 29402588 DOI: 10.1016/j.molmet.2018.01.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Gao J, Takeuchi H, Zhang Z, Fukuda M, Hirata M. Phospholipase C-related but catalytically inactive protein (PRIP) modulates synaptosomal-associated protein 25 (SNAP-25) phosphorylation and exocytosis. J Biol Chem 2012;287:10565-78. [PMID: 22311984 DOI: 10.1074/jbc.M111.294645] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
18 Hardy AB, Serino AS, Wijesekara N, Chimienti F, Wheeler MB. Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model. Diabetes Obes Metab 2011;13 Suppl 1:112-7. [PMID: 21824264 DOI: 10.1111/j.1463-1326.2011.01451.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
19 Ma X, Zhang Y, Gromada J, Sewing S, Berggren PO, Buschard K, Salehi A, Vikman J, Rorsman P, Eliasson L. Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors. Mol Endocrinol 2005;19:198-212. [PMID: 15459251 DOI: 10.1210/me.2004-0059] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
20 Briant LJ, Zhang Q, Vergari E, Kellard JA, Rodriguez B, Ashcroft FM, Rorsman P. Functional identification of islet cell types by electrophysiological fingerprinting. J R Soc Interface 2017;14:20160999. [PMID: 28275121 DOI: 10.1098/rsif.2016.0999] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
21 Suga S, Takeo T, Nakano K, Sato T, Igarashi T, Yamana D, Wakui M. Pertussis toxin-sensitive pathway inhibits glucose-stimulated Ca2+ signals of rat islet β-cells by affecting L-type Ca2+ channels and voltage-dependent K+ channels. Cell Calcium 2004;36:469-77. [DOI: 10.1016/j.ceca.2004.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Al-romaiyan A, Liu B, Docherty R, Huang G, Amiel S, Persaud SJ, Jones PM. Investigation of intracellular signalling cascades mediating stimulatory effect of a Gymnema sylvestre extract on insulin secretion from isolated mouse and human islets of Langerhans. Diabetes Obes Metab 2012;14:1104-13. [DOI: 10.1111/j.1463-1326.2012.01660.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Chen J, Ostenson CG. Glucagon release is regulated by tyrosine phosphatase and PI3-kinase activity. Biochem Biophys Res Commun 2004;325:555-60. [PMID: 15530428 DOI: 10.1016/j.bbrc.2004.10.077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
24 Yue JT, Burdett E, Coy DH, Giacca A, Efendic S, Vranic M. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes 2012;61:197-207. [PMID: 22106159 DOI: 10.2337/db11-0690] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
25 Brereton MF, Vergari E, Zhang Q, Clark A. Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination? J Histochem Cytochem. 2015;63:575-591. [PMID: 26216135 DOI: 10.1369/0022155415583535] [Cited by in Crossref: 87] [Cited by in F6Publishing: 63] [Article Influence: 14.5] [Reference Citation Analysis]
26 Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 2018;70:763-835. [PMID: 30232095 DOI: 10.1124/pr.117.015388] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 35.0] [Reference Citation Analysis]
27 Gaisano HY, Macdonald PE, Vranic M. Glucagon secretion and signaling in the development of diabetes. Front Physiol 2012;3:349. [PMID: 22969729 DOI: 10.3389/fphys.2012.00349] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
28 Sun FP, Song YG, Cheng W, Zhao T, Yao YL. Gastrin, somatostatin, G and D cells of gastric ulcer in rats. World J Gastroenterol 2002;8:375-8. [PMID: 11925629 DOI: 10.3748/wjg.v8.i2.375] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
29 Moriyama Y, Hayashi M. Glutamate-mediated signaling in the islets of Langerhans: a thread entangled. Trends Pharmacol Sci 2003;24:511-7. [PMID: 14559402 DOI: 10.1016/j.tips.2003.08.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
30 Tudurí E, Filiputti E, Carneiro EM, Quesada I. Inhibition of Ca 2+ signaling and glucagon secretion in mouse pancreatic α-cells by extracellular ATP and purinergic receptors. American Journal of Physiology-Endocrinology and Metabolism 2008;294:E952-60. [DOI: 10.1152/ajpendo.00641.2007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
31 Arnette D, Gibson TB, Lawrence MC, January B, Khoo S, Mcglynn K, Vanderbilt CA, Cobb MH. Regulation of ERK1 and ERK2 by Glucose and Peptide Hormones in Pancreatic β Cells. Journal of Biological Chemistry 2003;278:32517-25. [DOI: 10.1074/jbc.m301174200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
32 Watts M, Ha J, Kimchi O, Sherman A. Paracrine regulation of glucagon secretion: the β/α/δ model. Am J Physiol Endocrinol Metab 2016;310:E597-611. [PMID: 26837808 DOI: 10.1152/ajpendo.00415.2015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
33 Edlund A, Pedersen MG, Lindqvist A, Wierup N, Flodström-Tullberg M, Eliasson L. CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells. Sci Rep 2017;7:90. [PMID: 28273890 DOI: 10.1038/s41598-017-00098-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
34 Walker JN, Ramracheya R, Zhang Q, Johnson PR, Braun M, Rorsman P. Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diabetes Obes Metab 2011;13 Suppl 1:95-105. [PMID: 21824262 DOI: 10.1111/j.1463-1326.2011.01450.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 100] [Article Influence: 11.6] [Reference Citation Analysis]
35 Straub SG, Sharp GW. Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion. Am J Physiol Cell Physiol 2004;287:C565-71. [PMID: 15308461 DOI: 10.1152/ajpcell.00079.2004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
36 da Silva Xavier G, Farhan H, Kim H, Caxaria S, Johnson P, Hughes S, Bugliani M, Marselli L, Marchetti P, Birzele F, Sun G, Scharfmann R, Rutter J, Siniakowicz K, Weir G, Parker H, Reimann F, Gribble FM, Rutter GA. Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia 2011;54:819-27. [PMID: 21181396 DOI: 10.1007/s00125-010-2010-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
37 Castillo Bennett J, Roggero CM, Mancifesta FE, Mayorga LS. Calcineurin-mediated dephosphorylation of synaptotagmin VI is necessary for acrosomal exocytosis. J Biol Chem 2010;285:26269-78. [PMID: 20551332 DOI: 10.1074/jbc.M109.095752] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
38 Cervia D, Bagnoli P. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacol Ther 2007;116:322-41. [PMID: 17719647 DOI: 10.1016/j.pharmthera.2007.06.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
39 Göpel S, Zhang Q, Eliasson L, Ma XS, Galvanovskis J, Kanno T, Salehi A, Rorsman P. Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans. J Physiol 2004;556:711-26. [PMID: 14966302 DOI: 10.1113/jphysiol.2003.059675] [Cited by in Crossref: 119] [Cited by in F6Publishing: 111] [Article Influence: 7.0] [Reference Citation Analysis]
40 Abdul-Ghani M, DeFronzo RA. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. J Clin Endocrinol Metab 2007;92:1778-84. [PMID: 17327375 DOI: 10.1210/jc.2006-1515] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
41 Sakata N, Yoshimatsu G, Kodama S. Development and Characteristics of Pancreatic Epsilon Cells. Int J Mol Sci 2019;20:E1867. [PMID: 31014006 DOI: 10.3390/ijms20081867] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Singh B, Khattab F, Chae H, Desmet L, Herrera PL, Gilon P. KATP channel blockers control glucagon secretion by distinct mechanisms: A direct stimulation of α-cells involving a [Ca2+]c rise and an indirect inhibition mediated by somatostatin. Mol Metab 2021;53:101268. [PMID: 34118477 DOI: 10.1016/j.molmet.2021.101268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Olsen HL, Theander S, Bokvist K, Buschard K, Wollheim CB, Gromada J. Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells. Endocrinology 2005;146:4861-70. [PMID: 16081632 DOI: 10.1210/en.2005-0800] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 6.8] [Reference Citation Analysis]
44 Kolarow R, Brigadski T, Lessmann V. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci. 2007;27:10350-10364. [PMID: 17898207 DOI: 10.1523/jneurosci.0692-07.2007] [Cited by in Crossref: 126] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
45 De Marinis YZ, Zhang E, Amisten S, Taneera J, Renström E, Rorsman P, Eliasson L. Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCalpha and PKCdelta. Diabetologia 2010;53:717-29. [PMID: 20020096 DOI: 10.1007/s00125-009-1635-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
46 Rorsman P, Ashcroft FM. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. Physiol Rev 2018;98:117-214. [PMID: 29212789 DOI: 10.1152/physrev.00008.2017] [Cited by in Crossref: 241] [Cited by in F6Publishing: 183] [Article Influence: 60.3] [Reference Citation Analysis]
47 Kailey B, van de Bunt M, Cheley S, Johnson PR, MacDonald PE, Gloyn AL, Rorsman P, Braun M. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells. Am J Physiol Endocrinol Metab. 2012;303:E1107-E1116. [PMID: 22932785 DOI: 10.1152/ajpendo.00207.2012] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 8.9] [Reference Citation Analysis]
48 Hayashi M, Yamada H, Uehara S, Morimoto R, Muroyama A, Yatsushiro S, Takeda J, Yamamoto A, Moriyama Y. Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. J Biol Chem. 2003;278:1966-1974. [PMID: 12414805 DOI: 10.1074/jbc.m206758200] [Cited by in Crossref: 93] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
49 Le Marchand SJ, Piston DW. Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets. J Biol Chem 2010;285:14389-98. [PMID: 20231269 DOI: 10.1074/jbc.M109.069195] [Cited by in Crossref: 100] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
50 Furman B, Ong WK, Pyne NJ. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol. 2010;654:281-304. [PMID: 20217503 DOI: 10.1007/978-90-481-3271-3_13] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
51 Ng XW, Chung YH, Piston DW. Intercellular Communication in the Islet of Langerhans in Health and Disease. Compr Physiol 2021;11:2191-225. [PMID: 34190340 DOI: 10.1002/cphy.c200026] [Reference Citation Analysis]
52 Sun FP, Song YG. G and D cells in rat antral mucosa: an immunoelectron microscopic study. World J Gastroenterol 2003;9:2768-71. [PMID: 14669330 DOI: 10.3748/wjg.v9.i12.2768] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
53 Gilon P. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes. J Mol Biol 2020;432:1367-94. [PMID: 31954131 DOI: 10.1016/j.jmb.2020.01.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 18.0] [Reference Citation Analysis]
54 Yu Y, Ali DW, Chang JP. Three Native Somatostatin Isoforms Differentially Affect Membrane Voltage-Sensitive Ion Currents in Goldfish Somatotrophs: Goldfish somatostatins effects on ion currents. Journal of Neuroendocrinology 2011;23:82-93. [DOI: 10.1111/j.1365-2826.2010.02073.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
55 Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007;28:84-116. [PMID: 17261637 DOI: 10.1210/er.2006-0007] [Cited by in Crossref: 403] [Cited by in F6Publishing: 353] [Article Influence: 28.8] [Reference Citation Analysis]
56 Kawamori D, Welters HJ, Kulkarni RN. Molecular Pathways Underlying the Pathogenesis of Pancreatic α-Cell Dysfunction. In: Islam MS, editor. The Islets of Langerhans. Dordrecht: Springer Netherlands; 2010. pp. 421-45. [DOI: 10.1007/978-90-481-3271-3_18] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
57 Manning Fox JE, Gyulkhandanyan AV, Satin LS, Wheeler MB. Oscillatory membrane potential response to glucose in islet beta-cells: a comparison of islet-cell electrical activity in mouse and rat. Endocrinology 2006;147:4655-63. [PMID: 16857746 DOI: 10.1210/en.2006-0424] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
58 Tengholm A, Gylfe E. cAMP signalling in insulin and glucagon secretion. Diabetes Obes Metab 2017;19 Suppl 1:42-53. [PMID: 28466587 DOI: 10.1111/dom.12993] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 24.7] [Reference Citation Analysis]
59 Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2003;2:999-1017. [PMID: 14654798 DOI: 10.1038/nrd1255] [Cited by in Crossref: 379] [Cited by in F6Publishing: 307] [Article Influence: 22.3] [Reference Citation Analysis]
60 Strowski MZ, Blake AD. Function and expression of somatostatin receptors of the endocrine pancreas. Mol Cell Endocrinol 2008;286:169-79. [PMID: 18375050 DOI: 10.1016/j.mce.2008.02.007] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
61 Satin LS, Butler PC, Ha J, Sherman AS. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol Aspects Med 2015;42:61-77. [PMID: 25637831 DOI: 10.1016/j.mam.2015.01.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 83] [Article Influence: 18.2] [Reference Citation Analysis]
62 Amisten S, Meidute-Abaraviciene S, Tan C, Olde B, Lundquist I, Salehi A, Erlinge D. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 2010;53:1927-34. [PMID: 20526761 DOI: 10.1007/s00125-010-1807-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
63 Omar-Hmeadi M, Lund PE, Gandasi NR, Tengholm A, Barg S. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes. Nat Commun 2020;11:1896. [PMID: 32312960 DOI: 10.1038/s41467-020-15717-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
64 Theodoropoulou M, Stalla GK. Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol 2013;34:228-52. [PMID: 23872332 DOI: 10.1016/j.yfrne.2013.07.005] [Cited by in Crossref: 170] [Cited by in F6Publishing: 129] [Article Influence: 21.3] [Reference Citation Analysis]
65 Mari Y, Katnik C, Cuevas J. σ-1 Receptor Inhibition of ASIC1a Channels is Dependent on a Pertussis Toxin-Sensitive G-Protein and an AKAP150/Calcineurin Complex. Neurochem Res 2015;40:2055-67. [DOI: 10.1007/s11064-014-1324-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
66 Rai U, Thrimawithana TR, Valery C, Young SA. Therapeutic uses of somatostatin and its analogues: Current view and potential applications. Pharmacol Ther 2015;152:98-110. [PMID: 25956467 DOI: 10.1016/j.pharmthera.2015.05.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
67 Da Silva Xavier G. The Cells of the Islets of Langerhans. J Clin Med 2018;7:E54. [PMID: 29534517 DOI: 10.3390/jcm7030054] [Cited by in Crossref: 66] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
68 Kumar U, Grant M. Somatostatin and somatostatin receptors. Results Probl Cell Differ 2010;50:137-84. [PMID: 19859675 DOI: 10.1007/400_2009_29] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]